Ask AI
ELEVATE
ELEVATE: Phase II Trial of Elacestrant + Everolimus or Abemaciclib in ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Released: December 16, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 16, 2025